Pseudorabies virus EP0 protein counteracts an interferon-induced antiviral state in a species-specific manner

Journal of Virology

Volumn 80, Issue 21, 2006, Pages 10871-10873

  Brukman, Alla ^a   Enquist, L W ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PROTEIN EP0; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HOST RANGE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PSEUDORABIES HERPETOVIRUS; RESPIRATORY TRACT INFECTION; SPECIES DIFFERENCE; SURVIVAL; SWINE; SYMPTOM; VIRION; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; CATTLE; CELLS, CULTURED; HERPESVIRUS 1, SUID; HUMANS; INTERFERON TYPE I, RECOMBINANT; INTERFERONS; MICE; RATS; SPECIES SPECIFICITY; SUS SCROFA; VIRAL PROTEINS; VIRUS REPLICATION;

BOS TAURUS; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 3; MAMMALIA; RODENTIA; SUID HERPESVIRUS 1;

EID: 33750344767     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01308-06     Document Type: Article

References (22)

1. Brittle, E. E., A. E. Reynolds, and L. W. Enquist. 2004. Two modes of pseudorabies virus neuroinvasion and lethality in mice. J. Virol. 78:12951-12963.
2. Brukman, A., and L. W. Enquist. 2006. Suppression of the interferon-mediated innate immune response by pseudorabies virus. J. Virol. 80:6345-6356.
3. Cai, W. Z., and P. A. Schaffer. 1989. Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA. J. Virol. 63:4579-4589.
4. Eidson, K. M., W. E. Hobbs, B. J. Manning, P. Carlson, and N. A. DeLuca. 2002. Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection. J. Virol. 76:2180-2191.
5. Ellison, A. R., L. Yang, C. Voytek, and T. P. Margolis. 2000. Establishment of latent herpes simplex virus type I infection in resistant, sensitive, and immunodeficient mouse strains. Virology 268:17-28.
6. Garcia-Sastre, A., and C. A. Biron. 2006. Type I interferons and the virus-host relationship: a lesson in detente. Science 312:879-882.
7. Grob, P., V. E. Schijns, M. F. van den Broek, S. P. Cox, M. Ackermann, and M. Suter. 1999. Role of the individual interferon systems and specific immunity in mice in controlling systemic dissemination of attenuated pseudorabies virus infection. J. Virol. 73:4748-4754.
8. Lin, R., R. S. Noyce, S. E. Collins, R. D. Everett, and K. L. Mossman. 2004. The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes. J. Virol. 78:1675-1684.
9. Lopez, C. 1975. Genetics of natural resistance to herpesvirus infections in mice. Nature 258:152-153.
10. Melchjorsen, J., and S. R. Paludan. 2003. Induction of RANTES/CCL5 by herpes simplex virus is regulated by nuclear factor kappa B and interferon regulatory factor 3. J. Gen. Virol. 84:2491-2495.
11. Mossman, K. L., and J. R. Smiley. 2002. Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication. J. Virol. 76:1995-1998.
12. Ono, E., S. Watanabe, H. Nikami, T. Tasaki, and H. Kida. 1998. Pseudorabies virus (PRV) early protein 0 activates PRV gene transcription in combination with the immediate-early protein 1E180 and enhances the infectivity of PRV genomic DNA. Vet. Microbiol. 63:99-107.
13. Osorio, F. A., and D. L. Rock. 1992. A murine model of pseudorabies virus latency. Microb. Pathog. 12:39-46.
14. Parkinson, J., and R. D. Everett. 2000. Alphaherpesvirus proteins related to herpes simplex virus type I ICP0 affect cellular structures and proteins. J. Virol. 74:10006-10017.
15. Pomeranz, L. E., A. E. Reynolds, and C. J. Hengartner. 2005. Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine. Microbiol. Mol. Biol. Rev. 69:462-500.
16. Robbins, A. K., R. J. Watson, M. E. Whealy, W. W. Hays, and L. W. Enquist. 1986. Characterization of a pseudorabies virus glycoprotein gene with homology to herpes simplex type 1 and type 2 glycoprotein C. J. Virol. 58:339-347.
17. Roizman, B., and P. E. Pellett. 2001. The family Herpesviridae: a brief introduction, p. 2381-2397. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed., vol. 2. Lippincott Williams & Wilkins, Philadelphia, Pa.
18. Samaniego, L. A., L. Neiderhiser, and N. A. DeLuca. 1998. Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J. Virol. 72:3307-3320.
19. Sen, G. C. 2001. Viruses and interferons. Annu. Rev. Microbiol. 55:255-281.
20. Taylor, J. L., S. D. Little, and W. J. O'Brien. 1998. The comparative anti-herpes simplex virus effects of human interferons. J. Interferon Cytokine Res. 18:159-165.
21. Wagner, E. K., and D. C. Bloom. 1997. Experimental investigation of herpes simplex virus latency. Clin. Microbiol. Rev. 10:419-443.
22. Zhong, S., P. Salomoni, and P. P. Pandolfi. 2000. The transcriptional role of PML and the nuclear body. Nat. Cell Biol. 2:E85-E90.